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The network theory of the immune system proposes that idiotype-anti-idiotype 
interactions provide important  immunoregulatory controls (1). In many  experimental 
systems, the passive administration of heterologous anti-idiotypic ant ibody has been 
shown to enhance (2) or suppress (3) immune responses. In addition, spontaneous 
auto-anti-idiotypic antibody has been detected after antigenic challenge (4), generally 
appearing coincident with a decline in antibody titer (5). These findings have 
suggested that network controls might similarly regulate the formation of pathological 
autoantibodies (6). Two recent studies support this hypothesis. In one, rabbit  anti- 
(anti-thyroglobulin) idiotype prevented spontaneous auto immune thyroid disease in 
Buffalo rats (7). In the other, anti-(anti-DNA)-idiotype was found in the serum of 
systemic lupus erythematosus (SLE) 1 patients when they were in remission (8). 
In the current work, we have investigated the SLE mouse strain NZB for anti- 
(autoantibody)-idiotypic antibodies that might play an immunoregulatory role. With 
age, these mice spontaneously produce IgG anti-erythrocyte autoantibodies which 
mediate a severe Coombs-positive hemolytic anemia (9). The Fa hybrids of  NZB and 
several normal strains are known to develop a milder hemolytic disease with lower 
levels of Coombs antibodies (10). We have found that some of these hybrids sponta- 
neously produce high titers of  anti-(anti-erythrocyte)-idiotype antibodies that specif- 
ically recognize the NZB Coombs idiotypes. This finding suggests that network 
idiotype-anti-idiotype control might play a protective role in suppressing autoant ibody 
formation in these animals. 
M e t h o d s  
Mice. NZB and CBA/J mice were obtained from The Jackson Laboratory, Bar Harbor, 
ME. Some NZB mice used in early experiments came from Southwestern Medical School, 
Dallas, TX. (NZB × CBA)F1 mice were bred in the animal facilities at the University of North 
Carolina. 
Mice were bled from the retro-orbital plexus. To obtain erythrocyte (RBC) suspensions, 
blood was pipetted immediately into a large excess of Alsever's solution, centrifuged, and 
washed three times in saline before use. It was necessary to use fresh RBC for hemagglutination 
assays, as storage at 4°C overnight caused inconsistent results. Serum samples were obtained by 
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allowing blood to clot at room temperature and separating by centrifugation. Serum was stored 
in aliquots at -20°C before use. 
Hemagglutination Assays. For direct Coombs assays, washed RBC from 9-10-too-old NZB 
mice were resuspended to 1% in normal saline containing 1% bovine serum albumin (BSA) 
(Sigmal Chemical Co., St. Louis, MO). For indirect hemagglutination assays, a 10% suspension 
of washed normal mouse RBC (MRBC) from CBA mice was incubated with an equal volume 
of a 1:10 dilution of NZB serum for 30 rain at room temperature with rocking. In both assays, 
developing sera were diluted in BSA-normal saline in V-bottomed microtiter wells, and an 
equal volume of I% RBC suspension was added. Hemagglutination was read after 1 h at room 
temperature. Titers represent the highest dilution giving _>2+ agglutination on a 0-4+ scale. 
The developing antiserum used for screening for Coombs positivity was rabbit anti-mouse 
IgG, which was raised by immunization with an IgG myeloma and rendered gamma-specific 
by absorption with insolubilized IgM and lambda and kappa light chains. Detection of anti- 
RBC autoantibodies of differing subclasses was performed by using serial dilutions of rabbit 
antisera against mouse IgG1, IgG2a, IgG2b, and IgG3, all obtained from Litton Bionetics 
(Kensington, MD) and found to be monospecific by gel diffusion. (NZB × CBA)F1 hybrid sera 
were used as developing reagents in anti-idiotype assays. 
Hemagglutination Inhibition Assays. For confirmation of specificity, NZB sera were serially 
diluted and incubated for 30 min at room temperature with selected (CBA × NZB)FI sera at 
a concentration fourfold greater than the agglutination endpoint. Appropriate Coombs-positive 
RBC were then added. After 60 rain at room temperature, the hemagglutination inhibition 
titer was read as the highest NZB serum dilution to completely inhibit agglutination. 
Absorptions. Sepharose conjugates of monospecific goat anti-mouse IgG and of anti-trinitro- 
phenylated ovalbumin were kind gifts of Dr. Ellen Vitetta, University of Texas Health Science 
Center, Dallas, TX. Mouse IgG conjugated to Sepharose was provided by Dr. Stella Robinson 
(University of Texas Health Science Center). MRBC were coated with mouse IgG (Miles 
Laboratories, Elkhart, IN), by the chromium chloride technique (11). IgG-coated sheep RBC 
(SRBC) were prepared by immunizing CBA mice three times intraperitoneally with 0.1 ml of 
10% SRBC at 10-d intervals, and incubating the resulting immune serum (which contained 
high titer IgG anti-SRBC antibody) with SRBC for 30 min at room temperature, followed by 
extensive washing. 
Preparation of Pepsin Fragments of Coombs and Anti-Idiotype Antibodies. 200 /11 of each of four 
NZB indirect-Coombs-positive sera and four corresponding hybrid anti-idiotype sera were 
precipitated with 45% saturated ammonium sulfate. These partially-purified IgG fractions were 
digested with 2% pepsin at 37°C for 18 h in 0.5M acetate, pH 4.5. The resultant F(ab')~ 
fragments were absorbed with goat anti-mouse IgG (pFc'-specific)-Sepharose 4B. Absence of 
intact IgG and pFc' fragments was demonstrated in each case by double immunodiffusion 
analysis. Fab' fragments were prepared from these F(ab')2 preparations by reduction with 0.01 
M dithiothreitol and alkylation with a 10% M excess of iodoacetamide. 
CBA RBC were coated with Fab and F(ab')z fragments of NZB IgG by incubating 10% 
washed CBA RBC with equal volume of a 1:20 dilution of these preparations (equivalent to a 
1:40 dilution of whole serum). Indirect hemagglutination assays were done as described above. 
Re su l t s  
1;1 Sera Agglutinate NZB E~ythrocytes. We init ial ly observed that  sera from certain 
(NZB × CBA)F1 mice agglut ina ted  the RBC from some Coombs-posit ive NZB mice. 
RBC from Coombs-negat ive NZB mice were never agglut ina ted  by any  F1 sera. Sera 
from NZB mice that  had free-circulating an t i -RBC ant ibodies  (indirect Coombs 
positive) could be used to coat normal  M R B C  so that  they would be agglut ina ted  by 
the same F1 sera that  agglut ina ted  the donor  NZB RBC. The  activity of the F1 sera 
was age related, as 0 of 47 6-8-wk-old (CBA × NZB)F1 sera were able to agglut inate,  
compared  with 15 of 84 4-6-too-old sera. No difference was seen between F1 offspring 
of either CBA or NZB mothers. Agglu t ina t ing  activity was not  seen in the NZB or 
CBA parents,  nor  was it found in the unre la ted  mouse strains BALB/c  and  C57BL. 
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TABLE I 
Absorption of (CBA X NZB)FI Serum 57 Agglutinating Activity 
Titer -1 vs. NZB Titer -x vs. NZB Absorbant E1 RBC C2 RBC 
None 12,800 6,400 
Sepharose-goat anti-mouse IgG <10 <10 
Sepharose-goat anti-TNP-OVA* 6,400 6,400 
Sepharose-goat anti-KLH:~ 12,800 3,200 
Mouse IgG-coated SRBC§ 12,800 1,600 
Mouse IgG-eoated SRBCI] 25,600 6,400 
'* Trinitrophenylated ovalbumin. 
:~ Keyhole limpet hemocyanin. 
§ Coated with mouse anti-SRBC. 
][ Coated using CrCla. 
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TABLE II 
Reactivity of (NZB X CBA)FI Sera with NZB RBC (Reciprocal Titers) 
F1 NZB RBC 
serum C1 C2 D2 E1 F1 F2 H1 H2 J1 J2 K1 K2 
42 51,200 3,200 --* . . . . . . .  
45 1,280 - -  1,280 . . . . . . .  
47 12,800 - -  51,200 - -  - -  NT:]: NT NT NT NT 
54 102,400 2,560 - -  51 ,200  2 ,560 1,280 - -  - -  NT NT 
56 51,200 12,800 - -  - -  10,280 2,560 3,200 - -  3,200 3,200 
57 12,800 51,200 - -  12,800 200 - -  - -  NT NT NT 
63 640 - -  320 - -  - -  - -  NT NT NT NT 
66 102,400" 51,200 2,560 51,200 - -  - -  NT NT NT NT 
96 - -  - -  - -  12 ,800  . . . . . .  







:]: Not tested. 
Nature of the F1 Agglutinating Principle. T h e  f i nd ing  tha t  F1 sera w o u l d  a g g l u t i n a t e  
o n l y  C o o m b s - p o s i t i v e  M R B C  sugges ted  tha t  an  a n t i - a n t i b o d y  m i g h t  be  invo lved .  T o  
test this hypo thes i s ,  o n e  pos i t ive  F1 s e r u m  (serum 57) was a b s o r b e d  in severa l  ways  
a n d  tes ted  aga ins t  R B C  f rom two  C o o m b s - p o s i t i v e  N Z B  m i c e  (E l  a n d  C2).  As 
i n d i c a t e d  in T a b l e  I, this  p a r t i c u l a r  c o m b i n a t i o n  o f  sera a n d  cells g a v e  h i g h  t i ters  o f  
a g g l u t i n a t i o n .  A b s o r p t i o n  o f  t he  F1 s e r u m  w i t h  a c o l u m n  o f  a n t i - m o u s e  I g G  c o m p l e t e l y  
r e m o v e d  the  a g g l u t i n a t i n g  ac t iv i ty ,  w h e r e a s  con t ro l  c o l u m n s  h a d  no  s ign i f i can t  effect.  
T h i s  sugges ted  t h a t  an  a n t i b o d y  was respons ib le  for t he  ac t i v i t y  o f  t he  Fx se rum.  O n e  
poss ib i l i ty  was  r h e u m a t o i d  fac tor ;  however ,  s e r u m  57 fa i led  to a g g l u t i n a t e  S R B C  
c o a t e d  e i t he r  w i t h  m o u s e  a n t i - S R B C  a n t i b o d y  or  c o a t e d  nonspec i f i ca l ly  w i t h  n o r m a l  
m o u s e  I g G  ( T a b l e  I). M o u s e  I g G  b o u n d  to S e p h a r o s e  also fa i led  to r e m o v e  the  
a g g l u t i n a t i n g  ac t i v i t y  f rom a n o t h e r  F1 s e r u m  (not shown) .  S i m i l a r  a b s o r p t i o n  exper -  
i m e n t s  w i t h  four  o t h e r  F1 sera g a v e  c o m p a r a b l e  results.  
Specificity of Agglutinating Principle. O n e  o f  t he  mos t  s t r ik ing  fea tures  o f  t he  agg lu -  
t i n a t i o n  p h e n o m e n o n  was  the  speci f ic i ty  t h a t  i n d i v i d u a l  Ft  sera  s h o w e d  for i n d i v i d u a l  
N Z B  R B C .  A s u m m a r y  o f  t i t r a t ions  o f  10 r e a c t i n g  F1 sera w i t h  R B C  f r o m  e a c h  o f  12 
C o o m b s - p o s i t i v e  N Z B  m i c e  is s h o w n  in T a b l e  II.  A l t h o u g h  ce r t a in  sera a n d  ce r t a i n  
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TABLE III 
Lack of Correlation Between Coombs Antibody Subclass and Agglutination by Ft Serum 
Serum 
NZB RBC 
AI B1 B4 C1 C2 C4 D2 D3 F3 G1 G4 
Rabbit anti-IgG + + + + + + + + + + + 
Rabbit anti-IgG 1 + - - + + + + + - - + 
Rabbit anti-IgG2a + + - + + + + + + - - 
Rabbit anti-IgG2b - + + + + + + + - + - 
Rabbit anti-lgG3 - - - + + + + + + - - 
Fl serum 56 - - - + + - - + - - + 
F~ serum 143 . . . . . .  + -- + -- - 
TABLE IV 
Agglutination Inhibition by NZB Sera 
Reciprocal hemagglutina- 
Inhibiting serum tion-inhibition titer 








Mouse IgG (1 mg/ml) 








Mouse IgG (1 mg/ml) 
* < 1 0 .  
cells were  m o r e  r eac t ive  t h a n  o the r s ,  t h e  overa l l  p a t t e r n  sugges t ed  i n d i v i d u a l  specif ic-  
ities o f  a q u a l i t a t i v e  n a t u r e .  Fo r  e x a m p l e ,  F1 s e r u m  42 a g g l u t i n a t e d  R B C  C1 w i t h  a 
t i t e r  o f  51,200, b u t  fa i led  to a g g l u t i n a t e  e r y t h r o c y t e s  J 1. C o n v e r s e l y ,  s e r u m  143 fa i led  
to a g g l u t i n a t e  N Z B  R B C  C1 b u t  a g g l u t i n a t e d  R B C  J1 w i t h  a t i t e r  o f  12,800. It is 
un l ike ly  t h a t  th is  i n d i v i d u a l  spec i f ic i ty  r e p r e s e n t e d  the  r eac t iv i ty  o f  F1 r h e u m a t o i d  
fac tors  w i t h  se lec ted  subclasses  o f  m o u s e  IgG,  as we  f o u n d  no  o b v i o u s  c o r r e l a t i o n  o f  
t he  p a t t e r n  o f  r eac t iv i ty  o f  N Z B  e r y t h r o c y t e s  w i t h  h e t e r o l o g o u s  an t i - subc l a s s  a n t i s e r a  
c o m p a r e d  w i t h  t h e  p a t t e r n  o f  r eac t iv i ty  w i t h  t he  (CBA × NZB)F1 sera  (T ab l e  III). 
T h e  i n d i v i d u a l  spec i f ic i ty  o f  t h e  reac t iv i t i es  was  c o n f i r m e d  by  b l o c k i n g  e x p e r i m e n t s ,  
as s h o w n  in T a b l e  IV.  T h e  r eac t iv i ty  o f F 1  s e r u m  96 vs. N Z B  E1 R B C  (see T a b l e  II) 
c o u l d  be  i n h i b i t e d  by  s e r u m  f rom m o u s e  E1 b u t  no t  by  s e r u m  f rom six o t h e r  C o o m b s -  
pos i t ive  N Z B  mice ,  t he  R B C  o f  w h i c h  d i d  no t  reac t  w i t h  F1 s e r u m  96. S imi la r ly ,  
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TABLE g 
Agglutination of Autoantibody-coated RBC by Whole or Pepsin-digested (NZB X CBA)F1 Sera 
Uncoated 
F~ R e a g e n t  M R B C  
Normal MRBC coated with NZB Normal MRBC coated with N Z B  
whole sera F(ab')2 
N Z B - 5  N Z B - 1 2  N Z B - 2 2  N Z B - 2 5  N Z B - 5  N Z B - 1 2  N Z B - 2 2  N Z B - 2 5  
Mouse 2-5 whole serum* - + - + - + - + 
Mouse 2-5 F(ab')2 - - + - + - + - + 
Mouse 3-1  whole serum - + - - - + - - -  
M o u s e  3-1 F(ab% . . . . .  + - - 
M o u s e  4-3 whole serum - + - + - + + + - 
M o u s e  4-3 F(ab')2 - + + + - + + + - 
M o u s e  4-4 whole serum - + + + - + + - - 
M o u s e  4-4 F(ab')2 - -  + - - + + - - 
A n t i  K + anti ~ - + + + + + + - + 
Buffer . . . . . . . .  
* 1:20 dilution. 
:~ Mixture of 1:50 dilution of rnonospecific goat anti-mouse x and goat anti-mouse A sera 
TABLE VI 
Comparison of F(ab ')2 and Fab ' Agglutination of F(ab ')2 and Fab '-coated Mouse RBC 
Agglutinating FI m o u s e  
fragment 
F ( a b ' ) 2  coating reagent tab'  coating ruagen 
Saline N Z B - 5  N Z B - 1 2  N Z B - 2 2  N Z B - 2 5  N Z B - 5  N Z B - 1 2  N Z B - 2 2  N Z B - 2 5  
F ( a b ' ) 2 *  
F a b ' : ~  
Anti r + anti ~ §  
2 - 5  - -  + - -  + . . . .  
3 - I  - -  + . . . . . .  
4 - 3  - -  + + + . . . . .  
4 - 4  - -  + + + . . . . .  
2 - 5  . . . . . . . .  
3 -1  . . . . . . . .  
4 - 3  . . . . . . . .  
4 - 4  - -  + /  . . . . . . . .  
- -  + + + + + + + + 
* 1 : 2 0  dilution. 
l :  10 dilution. 
§ 1:50 dilution. 
serum 143 could be inhibited in its reactions with NZB J1 RBC by J1 serum, and also 
by serum from another NZB with which 143 reacted, D2. Thus, the individual NZB 
specificities seen by the F1 sera were represented consistently both on the NZB RBC 
and in their serum. 
Agglutination Required Fab'-Anti-Fab' Binding. If the agglutinating phenomenon we 
observed was due to idiotype-anti-idiotype interactions, the binding function of both 
the Fx serum and the NZB Coombs antibody should be contained in the Fob portion 
of IgG. To demonstrate this, 45% ammonium sulphate fractions of four individual F1 
sera and four NZB sera containing antibodies that reacted with at least some of the 
chosen F1 sera were all digested with pepsin and carefully purified free of intact IgG 
(see Methods). Due to the small volume involved, the resultant reagents could only be 
tested at a single dilution. The patterns of reactivity of the F1 F(ab')2 fragments were 
in general no different than those of the initial F1 sera (Table V). In addition, the F1 
serum [or F(ab')z] equally agglutinated normal MRBC coated with either NZB sera 
or with the F(ab')2 fragments purified from these sera (Table V). Furthermore, as 
shown in Table VI, reduction and alkylation of the FI F(ab')2, completely removed 
their agglutinating activities. Finally, normal MRBC coated with reduced and 
alkylated NZB F(ab')2 (i.e., Fab') were not agglutinated with F1 F(ab')2 fragments, 
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but still could be agglutinated with heterologous antibodies to mouse light chains 
(Table VI). 
Discussion 
The present data indicate that certain NZB F1 hybrids spontaneously produce 
antibodies directed against idiotypes of NZB Coombs anti-RBC antibodies. Evidence 
for the idiotype specificity of these antibodies derives from: (a) the selective reactivity 
of certain F1 sera with only certain NZB RBC (Table II); (b) the inhibition of F1 sera- 
NZB RBC agglutination by only those NZB sera from mice whose RBC were 
recognized by the F1 sera (Table IV); (c) the fact that F1 (F(ab')2 fragments 
agglutinated RBC coated with F(ab')2 fragments of the Coombs antibody, which 
indicated that Fab-Fab interactions were sufficient (Table V); and (d) the failure of 
F1 sera to agglutinate MRBC coated with NZB Fab', which indicated that the FI sera 
recognized determinants near the antigen-binding site of the Coombs antibody. That  
the observed agglutination might be due to rheumatoid factor was ruled out by the 
patterns of serum reactivity, the failure to absorb out activity with mouse IgG in a 
variety of forms, and the specificity for the F(ab')2 portion of the Coombs antibody 
molecule. In sum, then, all our data are consistent with the interpretation that the F~- 
agglutinating activity is an anti-(anti-RBC)-idiotypic antibody. An unlikely alterna- 
tive explanation would be that the F~ sera recognize V-region subgroups (12). This 
possibility cannot be formally excluded, because it has been shown that such markers 
on anti-Rh antibodies can be blocked by antigen binding (13, 14). However, we 
believe it improbable that such anti-V-region subgroup antibodies would sponta- 
neously arise in the F~, and that they would show the high degree of specificity for 
individual NZB Coombs antibodies (Tables II and IV). 
The observation of anti-idiotypic antibody to an autoantibody is in keeping with 
several experimental reports (15-17) of the formation of spontaneous anti-idiotype 
antibody against previously synthesized antibody directed against exogenous antigens. 
(NZB X CBA)F1 mice and other NZB hybrids develop hemolytic disease less severe 
than that of their NZB parent (I0). Furthermore, it has been reported that the 
Coombs antibody found in certain NZB hybrid mice is allotype restricted and 
therefore probably oligoclonal (18). The small amount and clonal restriction of NZB 
hybrid anti-RBC autoantibody may be the result of anti-idiotypic regulation (albeit 
imperfect) of these self-reactive specificities. It is of interest that we have not detected 
anti-idiotypic antibody against Coombs antibody either in NZB mice or in normal 
strains. 
That  a hemagglutination assay is capable of detecting anti-(anti-Coombs) idiotypic 
antibody may reveal something of the nature of the Coombs antibody. It is likely that 
one of the two Fab regions of the Coombs antibody must be relatively free for the 
anti-idiotypic antibody to recognize it. The fact that (anti-RBC)Fab'-coated MRBC 
can be agglutinated by anti-light chain antisera, but not by F1 anti-idiotype sera is in 
accord with this interpretation. Such a mechanism argues for substantial univalent 
attachment of the Coombs antibody to the RBC surface, a hypothesis consistent with 
low avidity and the presence of free antibody in the serum. It also implies that the 
epitopes recognized by the Coombs antibody are widely spaced on RBC. Similar 
conclusions were reached in studies of the reactivity of idiotypic, V-region framework, 
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and constant-region antisera with RBC coated with F(ab')2 or Fab '  fragments of anti- 
Rh antibodies (13, 14). 
The  data  thus far collected allow only a rough estimation of the size of  the repertoire 
of the NZB Coombs antibody. Cross-reactivity using anti-idiotype containing Fa sera 
suggests several shared idiotypes; however, the complex pattern of  reactivity (Table 
II) implies more than one anti-idiotypic specificity in some Fa sera and more than one 
Coombs idiotype on some NZB RBC. It will be important to quanti tate anti-idiotypic 
antibody and Coombs antibody levels over time in individual mice to define the 
relationship between RBC autoantibody levels and the appearance of anti-idiotype. 
With the availability of  anti-idiotypic reagents to the NZB Coombs antibody, direct 
functional studies will also be possible to elucidate the role of such antibodies in 
regulation of autoant ibody levels and auto immune disease. 
S u m m a r y  
The  Fa hybrids of NZB and several normal mouse strains are known to produce less 
anti-erythrocyte (Coombs) autoantibody and develop a milder hemolytic anemia 
than their NZB parents. We have found that serum from some (NZB × CBA)F1 mice 
agglutinated erythrocytes from certain Coombs-positive NZB mice, often in extremely 
high titer, whereas other (CBA X NZB)F1 sera agglutinated erythrocytes from 
different individual NZB mice. The  agglutination was due to antibody, but was not 
due to rheumatoid factor activity. Because F(ab')~ fragments of the F1 sera agglutin- 
ated erythrocytes coated with F(ab')2 fragments of the appropriate  NZB sera, the 
observed reactivity was probably caused by idiotype-anti-idiotype interactions. In 
addition, because F1 sera could not agglutinate mouse erythrocytes coated with 
monovalent NZB Fab'  fragments, the recognized idiotype probably involved the 
antigen-binding site. Anti-idiotypic antibodies against anti-erythrocyte autoantibodies 
may play an important  role in the regulation of autoantibody formation. 
We thank Ms. Debbie Billings for her assistance in preparing the manuscript. 
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